125 related articles for article (PubMed ID: 6648143)
1. An analysis of survival differences between clinically and screen-detected cancer patients.
Habbema JD; van Oortmarssen GJ; van Putten DJ
Stat Med; 1983; 2(2):279-85. PubMed ID: 6648143
[TBL] [Abstract][Full Text] [Related]
2. Screening for lung cancer. Another look; a different view.
Strauss GM; Gleason RE; Sugarbaker DJ
Chest; 1997 Mar; 111(3):754-68. PubMed ID: 9118717
[TBL] [Abstract][Full Text] [Related]
3. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
[TBL] [Abstract][Full Text] [Related]
4. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
5. Non-parametric estimation of the post-lead-time survival distribution of screen-detected cancer cases.
Xu JL; Prorok PC
Stat Med; 1995 Dec; 14(24):2715-25. PubMed ID: 8619110
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the survival of cancer cases detected by screening.
Walter SD; Stitt LW
Stat Med; 1987 Dec; 6(8):885-900. PubMed ID: 3438615
[TBL] [Abstract][Full Text] [Related]
7. Estimates of lead time and length bias in a breast cancer screening program.
Shwartz M
Cancer; 1980 Aug; 46(4):844-51. PubMed ID: 7397650
[TBL] [Abstract][Full Text] [Related]
8. Continuous tumour growth models, lead time estimation and length bias in breast cancer screening studies.
Abrahamsson L; Isheden G; Czene K; Humphreys K
Stat Methods Med Res; 2020 Feb; 29(2):374-395. PubMed ID: 30854935
[TBL] [Abstract][Full Text] [Related]
9. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
[TBL] [Abstract][Full Text] [Related]
10. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
11. Update of the Swedish two-county program of mammographic screening for breast cancer.
Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
[TBL] [Abstract][Full Text] [Related]
12. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer.
Moss SM; Summerley ME; Thomas BT; Ellman R; Chamberlain JO
J Epidemiol Community Health; 1992 Aug; 46(4):362-4. PubMed ID: 1431707
[TBL] [Abstract][Full Text] [Related]
13. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
[TBL] [Abstract][Full Text] [Related]
14. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
15. Measuring effectiveness of lung cancer screening: from consensus to controversy and back.
Strauss GM
Chest; 1997 Oct; 112(4 Suppl):216S-228S. PubMed ID: 9337293
[TBL] [Abstract][Full Text] [Related]
16. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening.
Shapiro S; Venet W; Strax P; Venet L; Roeser R
Natl Cancer Inst Monogr; 1985 May; 67():65-74. PubMed ID: 4047153
[TBL] [Abstract][Full Text] [Related]
17. [Problems in using survival data of cancer patients as a method of gauging the effectiveness of cancer control efforts].
Oshima A
Gan No Rinsho; 1988 Oct; 34(12):1637-41. PubMed ID: 3193607
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer screening: improved survival but no reduction in deaths--the role of "overdiagnosis".
Parkin DM; Moss SM
Cancer; 2000 Dec; 89(11 Suppl):2369-76. PubMed ID: 11147614
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region.
Wu JC; Anttila A; Yen AM; Hakama M; Saarenmaa I; Sarkeala T; Malila N; Auvinen A; Chiu SY; Chen TH
Breast Cancer Res Treat; 2010 Jun; 121(3):671-8. PubMed ID: 19890708
[TBL] [Abstract][Full Text] [Related]
20. Chest X-ray screening improves outcome in lung cancer. A reappraisal of randomized trials on lung cancer screening.
Strauss GM; Gleason RE; Sugarbaker DJ
Chest; 1995 Jun; 107(6 Suppl):270S-279S. PubMed ID: 7781405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
